COVID-19 in Systemic Lupus Erythematosus patients treated with belimumab: a retrospective clinical study
ConclusionThis study concluded that treatment with belimumab did not increase susceptibility to COVID-19 and beneficially alleviated the symptoms of COVID-19.
Source: Immunologic Research - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Coronavirus | COVID-19 | Lupus | Respiratory Medicine | SARS | Study